Clinical and bacteriological evaluation of the efficacy of piperacillin in children with pneumonia

We aimed to prospectively evaluate the clinical and bacteriological effects of piperacillin in children with pneumonia. Twenty-eight patients (6 months to 5 years of age) with pneumonia were treated with piperacillin. In the same period, 95 strains of Haemophilus influenzae and 41 strains of Streptococcus pneumoniae were isolated in our department and the minimum inhibitory concentration (MIC) of piperacillin was determined. The clinical efficacy of piperacillin was excellent in 4 cases, good in 23, and fair in 1; the response rate was 96.4% (27/28). Among the isolates from our department, there were 4 strains (9.8%) of penicillin-susceptible S. pneumoniae (PSSP), 32 strains (78.0%) of penicillin-intermediate-resistant S. pneumoniae (PISP), and 5 strains (12.2%) of penicillin-resistant S. pneumoniae (PRSP). Against S. pneumoniae, the MIC₅₀ and MIC₉₀ for piperacillin were 0.5 μg/ml and 2 μg/ml, respectively. Panipenem showed the best results, followed by piperacillin, ampicillin, and flomoxef. Among the isolates from our department, there were 51 strains (53.7%) of β-lactamase-negative ampicillin-susceptible H. influenzae, 42 strains (44.2%) of β-lactamase-negative ampicillin-resistant H. influenzae, 1 strain (1.1%) of β-lactamase-positive ampicillin-resistant H. influenzae, and 1 strain (1.1%) of β-lactamase-positive amoxicillin-clavulanic acid-resistant H. influenzae. The MIC₅₀ and MIC₉₀ for piperacillin against H. influenzae were 0.0625 μg/ml and 0.125 μg/ml, respectively. Tazobactam/piperacillin and piperacillin showed the best results, followed by panipenem, ampicillin, and flomoxef. Piperacillin proved to be very useful for the treatment of pneumonia in children.     

Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant <Emphasis Type="Italic">Staphylococcus aureus</Emphasis> and the genes encoding aminoglycoside-modifying enzymes

It is generally accepted that methicillin-resistant Staphylococcus aureus (MRSA) is also resistant to aminoglycoside antibiotics. We investigated trends of gentamicin and arbekacin susceptibilities and the prevalence of the genes encoding aminoglycoside-modifying enzymes (AMEs) for a total of 218 strains of MRSA isolated from blood specimens obtained from 1978 through 2002 in one hospital. The minimum inhibitory concentrations of gentamicin at which 50% of the strains were inhibited (MIC₅₀) were ≥128 and 32 μg/ml for isolates obtained from 1978 to 1984 and from 1985 to 1989, respectively, and 0.5 μg/ml for isolates obtained from 1990 to 2002. The MIC₉₀ of gentamicin was consistently ≥128 μg/ml. Investigation of the occurrence of AME revealed that the MIC₅₀ of gentamicin was highly correlated with the presence of aac(6′)/aph(2″) encoding aminoglycoside acetyl/phosphotransferase. The MIC₅₀ of arbekacin was 2 μg/ml for strains isolated in 1978–1984 and ≤0.5 μg/ml for strains isolated from 1985 to 2002. The MIC₉₀ of arbekacin was 8 μg/ml for the strains isolated in 1978–1989 and 1 to 2 μg/ml for strains isolated in 1990–2002. Though it has been established that AAC(6′)/APH(2″) modifies arbekacin, the trend of arbekacin resistance was not necessarily consistent with the presence of this enzyme. However, the prevalence of both aac(6′)/aph(2″) and aph(3′)-III in the strains isolated from 1978 through 2002 was correlated with the MIC₉₀ values of arbekacin. Thus, it is most likely that APH(3′)-III, in addition to AAC(6′)/APH(2″), is somehow involved in arbekacin resistance in S. aureus. Our results imply that gentamicin- and arbekacin-resistant MRSAs have consistently decreased for the past 25 years and that this finding is, most likely, attributable to the declining prevalence of genes encoding for AMEs.     

Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases

In 2003, the Japan Society for Infectious Diseases in Otolaryngology conducted its third nationwide survey of clinical isolates from otolaryngological infectious diseases. We selected three primary causative organisms of otolaryngological infectious diseases, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella Branhamella catarrhalis, and evaluated their sensitivities to tosufloxacin (TFLX), a new oral quinolone, because the survey revealed a rise in drug-resistant strains, suggesting potential problems with the antibiotics commonly used against these organisms. The minimum inhibitory concentration (MIC)₉₀ values of TFLX against S. pneumoniae, H. influenzae, and M. catarrhalis were 0.25 μg/ml, ≤0.06 μg/ml, and ≤0.06 μg/ml respectively, and TFLX was shown to be as effective as or superior to other new quinolones. In addition, TFLX showed sufficient antimicrobial effects against frequently detected drug-resistant bacteria such as penicillin-resistant S. pneumoniae (PRSP) and β-lactamase-negative, ampicillin-resistant strains of H. influenzae (BLNAR). Furthermore, only a few strains of bacteria showed resistance to TFLX.     

Bactericidal activities of parenteral antibiotics and genotype of penicillin-binding protein in Streptococcus pneumoniae and Haemophilus influenzae isolated from children's blood

A total of 16 isolates of Streptococcus pneumoniae and 18 isolates of Haemophilus influenzae were obtained from the blood of children admitted to the pediatric wards of hospitals in Hokkaido Kamikawa subprefecture between January 2003 and December 2005. The ages of the patients with S. pneumoniae or H. influenzae infection ranged from 2 months to 9 years and from 1 month to 4 years, respectively. The diagnoses of S. pneumoniae infection were as follows: pneumonia in 8 patients, occult bacteremia in 5 patients, and meningitis in 3 patients. The diagnoses of H. influenzae were: meningitis in 6 patients, pneumonia in 4 patients, occult bacteremia in 4 patients, epiglotitis in 2 patients, and facial cellulitis in 2 patients. Out of 16 S. pneumoniae isolates, penicillin-resistant strains with a mutation of 3 genes were observed in 7 children, and penicillin intermediate-resistant strains with a mutation of 1 or 2 genes were observed in 8 children. Out of 18 H. influenzae isolates, the β-lactamase-negative ampicillin-resistant strain with a substitution of 2 points in the ftsI gene was revealed in 2 children, the β-lactamase-negative ampicillin-resistant strain with a substitution of 1 point in the ftsI gene was observed in 4 children, the β-lactamase-positive amoxicillin/clavulanic acid-resistant strain with blaTEM-1 and ftsI with 2 substitutions in the ftsI gene was observed in 3 children, and the β-lactamase-positive ampicillin-resistant strain with blaTEM-1was not observed. The MBC90s of ampicillin, ceftriaxone, cefotaxime, meropenem, panipenem, and vancomycin against S. pneumoniae were 8 μg/ml, 1 μg/ml, 1 μg/ml 1 μg/ml, 0.25 μg/ml, and 0.5 μg/ml, respectively. Those of ampicillin, piperacillin, ceftriaxone, cefotaxime, meropenem, and panipenem against H. influenzae were >128 μg/ml, >128 μg/ml, 0.25 μg/mL, 1 μg/ml, 0.12 μg/ml, and 0.5 g/ml, respectively. It is suggest that the minimum bactricidal concentration (MBC) was dissociated from the minimum inhibitory concentration (MIC) in S. pneumoniae and H. influenzae with abnormal pbp genes.     

Differences in antimicrobial susceptibility breakpoints for <Emphasis Type="Italic">Pseudomonas aeruginosa</Emphasis>, isolated from blood cultures,set by the Clinical and Laboratory Standards Institute (CLSI) and the Japanese Society of Chemotherapy

A study was made of the antimicrobial susceptibility to and efficacy of various kinds of antimicrobial agents against 179 strains of Pseudomonas aeruginosa that were isolated from blood cultures at Kansai Medical University Hospital from 1990 through 2004. The annual detection rate was highest in 1994, at 22 strains (6.5%). There were 9 multidrug resistant strains of Pseudomonas aeruginosa (5.0%). Among 14 antimicrobial agents tested for measurements, ciprofloxacin (CPFX) showed the best minimum inhibitory concentration (MIC) 50 value, of 0.25 μg/ml, followed by pazufloxacin (PZFX) and biapenem (BIPM), each at 0.5 μg/ml. When the period of 15 years was divided into three stages, the MIC50 value for each antimicrobial agent was highest in the middle stage (1995 to 1999). Assuming that the percentage of sensitive strains according to the breakpoints set by the Clinical and Laboratory Standards Institute (CLSI) represents the antimicrobial susceptibility rate, amikacin (AMK) showed the best value, of 85.5%. According to the sepsis breakpoint set by the Japanese Society of Chemotherapy (JSC), the efficacy of CPFX showed the highest rate (77.1%) of all the antimicrobial agents tested. Among β-lactams, BIPM showed the highest efficacy rate, of 67.0%. When the efficacy rates were compared with each other, the difference in efficacy rate between the breakpoint set by the CLSI and the sepsis breakpoint set by the JSC was large for β-lactams. Comparisons made based on the CLSI criteria showed no difference in cross-resistance rates between CPFX, meropenem (MEPM), and BIPM. However, when comparisons were made using the JSC sepsis breakpoint, MEPM showed a cross-resistance rate of 87.8%, while the rate for BIPM was lower, at 56.1%, with the χ² test showing a significant difference, at P = 0.0014. In accordance with the pharmacokinetics/pharmacodynamics theory that has been advocated, breakpoints which are more suitable for the clinical setting in Japan should be set so that more effective and more appropriate treatment can be carried out.     

Molecular characteristics of Staphylococcus aureus isolated from intensive care units of Children's Hospital北大核心CSCD

Objective To study the molecular characteristics of the Staphylococcus aureus isolated from the intensive care units (ICUs) of children's hospital. Methods From January 2016 to December 2016, a total of 39 S. aureus strains were collected and identified from various clinical specimens that were obtained from patients who were confined in the neonatal and pediatric ICUs of Beijing Children's Hospital. Methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) were identified using the cefoxitin disc method and the detection of the mecA gene. Multilocus sequence typing (MLST) and spa typing were analyzed using the PCR, and the staphylococcal chromosomal cassette mec (SCCmec) type was analyzed for the MRSA isolates. Twenty-one superantigen genes and the Panton-Valentine leukocidin (pvl) gene were also detected by PCR. Their susceptibility to 12 antibiotics was evaluated using the E-test method. The differences in prevalence of virulence gene?, and antimicrobial resistance were compared between the MRSA and MSSA isolates by Fishers exact test. Results All the S. aureus strains were isolated from secretion inside the airway of pneumonia (including severe pneumonia), the blood of patients with bacteremia, and exudate of skin and soft tissue infections. ST59-SCCmec IVa-t437 (55.6%) and ST398-t571 (28.6%) were the most predominant clones of MRSA and MSSA, respectively. Of the 39 isolates, 26 strains (66.7%) had at least one superantigen gene, and seb (38.5%), sek (30.8%), and seq (20.5%) were the most common genes; seb-sek-seq (18.0%) was the main virulence genotype. The pvl genes positive rate was 25.6%, and no significant difference between MRSA and MSSA was observed (P > 0.05). Notably, 79.9% of the S. aureus isolates were multidrug resistant, and 94.9%, 53.8′%, and 51.3% of the isolates were resistant to erythromycin, clindamycin, and chloramphenicol, respectively. The tested isolates were susceptible to trimethoprim/sulfamethoxazole, rifampicin, and vancomycin. Conclusions The S. aureus strains from the ICUs of childrens hospital were isolated from the secretion inside the airway of pneumonia (including severe pneumonia), the blood of patients with bacteremia, and exudate of skin and soft tissue infections. ST59-SCCmecIVa-t437 (55.6%) and ST398-t571 (28.6%) were the common clones of MRSA and MSSA, respectively. The prevalence of superantigen genes and the multidrug resistant.rate were relatively high.     

In vitro synergistic effects of double combinations of β-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae

In Japan, Neisseria gonorrhoeae, a sexually transmitted pathogen, has recently shown significant resistance to various antimicrobial agents. In this study, a checkerboard method was utilized to investigate the in vitro activities of cefixime (CFIX), cefteram (CFTM), or amoxicillin (AMPC) in combination with azithromycin (AZM) against 25 clinical isolates of N. gonorrhoeae. Synergy, defined as a fractional inhibitory concentration (FIC) index of less than or equal to 0.50, was observed in 32% of isolates with CFIX+AZM, 12% of isolates with CFTM+AZM, and 4% of isolates with AMPC+AZM. Moreover, partial synergy, defined as an FIC index of greater than 0.50 and less than 1, was observed in 44% of isolates with CFIX+AZM, 68% of isolates with CFTM+AZM, and 52% of isolates with AMPC+AZM. In particular, as a result of the combination of CFIX and AZM, for all isolates, significant reductions were observed in the median CFIX minimum inhibitory concentration (MIC; from 0.25 to 0.008 μg/ml; P < 0.0001) and the median AZM MIC (from 0.12 to 0.03 μg/ml; P < 0.0001). However, antagonism, defined as an FIC index of greater than 1, was observed in only 4% of the isolates with both CFIX+AZM and CFTM+AZM, while it was seen in 12% of the isolates with AMPC+AZM. To our knowledge, this is the first study to demonstrate that the in vitro activity of CFIX against N. gonorrhoeae can be significantly enhanced in combination with AZM.     

整合子在鲍曼不动杆菌耐药中的作用研究

Objective To investigate the drug-resistant status of Acinetobacter baumannii in clinical strains isolated from our hospital,and get to know the distribution of integrons carried by Acinetobacter baumannii,analyze the correlation between integron and drug-resistant of Acinetobacter baumannii..Methods Collected 85 Acinetobacter baumannii isolated in our lab,the drug-sensitivity tests were completed by the method of KB,the integrase genes were amplified by polymerase chain reaction(PCR),and identified the type of integron..Analyzed the correlation between the drug-resistant and integron in Acinetobacter baumannii..The open reading frame of integron were amplified by PCR,the polymorphism of integron was identified,and sequenced the PCR products.Results Except for Imipenem and Cefoperazone/ sulbactam(drug resistant rate less than 10%),the drug resistant rate of other 15 antibacterial was no more than 30% among the 85 Acinetobacter baumannii isolated in our lab..66.1 %(57/85) stains carried the integrons I,we didn't find out the integron Ⅱ and Ⅲ.The drug-resistant rates of Acinetobacter baumannii with integron were higher than that of Acinetobacter baumannii without integron.The length of amplified products in variable region of open reading frame of integron varied from 03 to 25kb,.The sequencing results confirmed the integron included multidrug resistant gene code.Conclusion In our hospital,the drug-resistant rate of Acinetobacter baumannii was high,and the majority were multidrug resistant strains.The drug-resistant rate of Acinetobacter baumannii was enhanced with integron,The multidrug resistant of Acinetobacter baumannii was associated with integrons.     

肺炎克雷伯菌药敏分析及其超广谱β内酰胺酶基因分型研究

目的 对北京大学人民医院分离的肺炎克雷伯菌进行药敏分析及ESBL型别测定,为控制院内肺炎克雷伯菌感染提供依据.方法 收集北京大学人民医院2001-2007年分离的1 205株肺炎克雷伯菌,采用Vitek-2全自动药敏鉴定分析仪对菌株进行鉴定及药敏试验,采用WHONET 5.3软件进行药敏结果分析,PCR法检测ESBL基因型别,比较分析各种药物敏感率和基因型比率特征和差异.结果 2001-2007年肺炎克雷伯菌中产ESBL比例逐年增加:2001年为15.8% (40/253),2002年为20.9% (53/253),2003年为32.8% (42/128),2004年为32.8% (45/137),2005年为36.6% (60/164),2006年为45.3% (68/150),2007年为45.6% (73/160).ESBL阳性菌株中SHV基因检出比例最大,2007年为83.6%(61/73).ESBL阳性菌株中CTX-M基因检出率逐年增加,2007年为54.8%(40/73).携带单一SHV基因菌株与同时携带SHV、CTX-M基因菌株对头孢他啶、头孢曲松及头孢噻肟的耐药率差异有统计学意义(χ2值分别为20.26、32.03、29.65,P均＜0.05);携带单一SHV基因菌株与同时携带SHV、TEM基因菌株对头孢他啶、头孢曲松及头孢噻肟的耐药率差异有统计学意义 (χ2值分别为7.01、9.93、11.01,P均＜0.05);携带单一SHV基因菌株与同时携带SHV、OXA基因菌株对头孢他啶、头孢曲松及头孢噻肟的耐药率有统计学差异 (χ2值分别为14.11、17.58、11.54,P均＜0.05);携带CTX-M基因菌株与同时携带SHV、CTX-M基因菌株对头孢他啶耐药率差异有统计学意义(χ2=23.61,P＜0.05);携带TEM基因菌株与同时携带SHV、TEM基因菌株对头孢他啶耐药率差异有统计学意义(P=0.01).结论 肺炎克雷伯菌产ESBL逐年增加,以SHV型为主,携带CTX-M型ESBL基因菌株逐年增多.

Abstract：

Objective To analyze the antibiotic susceptibility, ESBL genotype of clinical Klebsiella pneumoniae strains isolated from People′s hospital and facilitate the control of resistance spread. Methods Identification and antibiotic susceptibility tests of 1 205 strains from 2001 to 2007 were done by VITEK-2 system.The antibiotic susceptibility results were analyzed by whonet5.3.The ESBL gene was detected by PCR and the Chi-square test was used for statistical analysis.Results The rate of ESBL-producing strains in klebsiella pneumoniae has increased from 2001 to 2007[18.8% (40/213) in 2001, 20.9% (53/253) in 2002, 32.8% (42/128) in 2003, 33.6% (45/137) in 2004, 36.6% (60/164) in 2005, 45.3% (68/150) in 2006 and 45.6% (73/160) in 2007].The SHV gene was the most dominant in ESBL genotypes.There were 83.3% (50/60) ESBL strains in 2005 with SHV gene, 82.3%(56/68) in 2006 and 83.6%(61/73) in 2007.The rated of strains with CTX-M gene were increasing.There were 26.7%(16/60) ESBL strains with CTX-M gene in 2005, 36.7%(25/68) in 2006 and 54.8%(40/73) in 2007.The isolates with more than one type of ESBL gene were increasing.There were 45%(27/60) ESBL strains in 2005 with two types of ESBL gene, and no one had more than two types of ESBL gene in that year.There were 47.9%(35/73) ESBL strains in 2007 with two types of ESBL gene.In 2007 there were 9.6%(7/73) and 2.7%(2/73) ESBL strains with three types and four types of ESBL gene respectively.There was a statistical difference between the antibiotic resistance rates of cefotaxime, ceftriaxone and ceftazidime in SHV-gene-phore strains (χ2=13.22, P＜0.01).The strains with SHV gene were more resistant to cefotaxime than ceftriaxone and ceftazidime.There also was a statistical difference of the antibiotic resistance rate of cefotaxime, ceftriaxone and ceftazidime between strains with TEM gene (χ2=9.91, P＜0.01) and CTX-M gene (χ2=34.84, P＜0.01) respectively.None of the strains with CTX-M gene was sensitive to cefotaxime, and they were more resistant to ceftriaxone than ceftazidime.The strains with TEM gene were more resistant to cefotaxime than ceftriaxone and ceftazidime.There were statistical differences of the antibiotic resistance rate to cefotaxime (χ2=29.65, P＜0.01), ceftriaxone (χ2=20.26, P＜0.01) and ceftazidime (χ2=20.26, P＜0.01) between the strains with SHV gene only and strains with SHV and CTX-M gene concurrently.There were also statistical differences of the antibiotic resistance rates to cefotaxime (χ2=11.01, P＜0.01), ceftriaxone (χ2=9.93, P＜0.01) and ceftazidime (χ2=7.01, P＜0.01) between the strains with SHV gene only and strains with SHV and TEM gene concurrently.The antibiotic resistance rates to cefotaxime (χ2=11.54, P＜0.01), ceftriaxone (χ2=17.58, P＜0.01) and ceftazidime (χ2=14.11, P＜0.01) were statistically different between the strains with SHV gene only and strains with SHV and OXA gene concurrently.The antibiotic resistance rates to ceftazidime (χ2=23.61, P＜0.01) were statistically different between the strains with CTX-M gene only and strains with SHV and CTX-M gene concurrently. There was no statistical difference in antibiotic resistance rates to cefotaxime (χ2=3.55, P＜0.01) and ceftriaxone (χ2=3.35, P＜0.01) between the strains with CTX-M gene only and strains with SHV and CTX-M gene concurrently. The antibiotic resistance rates to ceftazidime (P=0.01) were statistically different between the strains with only TEM gene and strains with SHV and TEM gene concurrently, and there was no statistical difference of the antibiotic resistance rates to cefotaxime (P=0.29) and ceftriaxone (P=0.26) between the strains with TEM gene only and strains with SHV and TEM gene concurrently. ConclusionsThe producing rate of ESBL is increasing year after year and the SHV type of ESBL is the dominant one.Strains with more than one type of ESBL gene are increasing.The antibiotic resistance rates to cefotaxime, ceftriaxone and ceftazidime are statistically different between strains with same ESBL genotype.     

铜陵市部分医院细菌耐药性监测与分析

Objective To investigate the bacterial resistance of clinical isolates collected in Tongling area.Methods The clinical isolates were collected in Tongling area from Jananuary to December in 2007.Antimicrobial susceptibility test were conducted by Kirby-Bauer method.Results Of 1375 clinical isolates,399 strains(29.0%)were gram positive bacteria,and 976 strains(71.0%)were gram negative bacteria.Methicillin resistant staphylococcus aureus(MRSA)accounted for 18.4% of staphylococcus aureus,while methicillin resistant coagulase negative staphylococci(MRCNS)were 70.0% of coagulase negative staphylococci(CNS)respectively.MRSA and MRCNS were highly resistant to gentamicin,ciprofloxacin,clindamycin and erythromycin;but displayed lower resistance to rifampicin,chloramphenicol and nitrofurantion.No vancomycin-resistant staphylococcus strain was found.The resistance rates of Enterococcus faecalis were relatively low to penicillin,ampicillin,nitro furantion,fosfomycin and chloramphenicol.No vancomycin or teicoplanin-resistant enterococcus faecalis was isolated.The resistance rates of E.faecium were lower to fosfomycin and chloramphenicol.Two strains of vancomycin-resistant E.faecium were identified.About of 49.3% of E.coli and 35.9% of Klebsiella isolates produced extended-spectrum β-lactamases(ESBLs).The resistance rates of ESBLs-producing strains to 20 antimicrobial agents were much higher than those of ESBLs nonproducing ones.No imipenem or meropenem-resistant isolate was found.The resistance rate of non-fermenters was lower to imipenem,meropenem,cefoperazone-sulbactam,piperacillin-tazobactam,ceftazidime,cefepime,amikacin or ciprofloxacin.Conclusion The resistance rate of gram positive bacteria is lower to glycopeptides.The resistance rate of gram negative bacilli is lower to imipenem,meropenem,cefoperazone-sulbactam,and piperacillin-tazobactam.Surveillance of bacterial resistance is of great importance for rational use of antibiotics and reducing the emergence of resistance.     

铜陵市部分医院细菌耐药性监测与分析

Objective To investigate the bacterial resistance of clinical isolates collected in Tongling area.Methods The clinical isolates were collected in Tongling area from Jananuary to December in 2007.Antimicrobial susceptibility test were conducted by Kirby-Bauer method.Results Of 1375 clinical isolates,399 strains(29.0%)were gram positive bacteria,and 976 strains(71.0%)were gram negative bacteria.Methicillin resistant staphylococcus aureus(MRSA)accounted for 18.4% of staphylococcus aureus,while methicillin resistant coagulase negative staphylococci(MRCNS)were 70.0% of coagulase negative staphylococci(CNS)respectively.MRSA and MRCNS were highly resistant to gentamicin,ciprofloxacin,clindamycin and erythromycin;but displayed lower resistance to rifampicin,chloramphenicol and nitrofurantion.No vancomycin-resistant staphylococcus strain was found.The resistance rates of Enterococcus faecalis were relatively low to penicillin,ampicillin,nitro furantion,fosfomycin and chloramphenicol.No vancomycin or teicoplanin-resistant enterococcus faecalis was isolated.The resistance rates of E.faecium were lower to fosfomycin and chloramphenicol.Two strains of vancomycin-resistant E.faecium were identified.About of 49.3% of E.coli and 35.9% of Klebsiella isolates produced extended-spectrum β-lactamases(ESBLs).The resistance rates of ESBLs-producing strains to 20 antimicrobial agents were much higher than those of ESBLs nonproducing ones.No imipenem or meropenem-resistant isolate was found.The resistance rate of non-fermenters was lower to imipenem,meropenem,cefoperazone-sulbactam,piperacillin-tazobactam,ceftazidime,cefepime,amikacin or ciprofloxacin.Conclusion The resistance rate of gram positive bacteria is lower to glycopeptides.The resistance rate of gram negative bacilli is lower to imipenem,meropenem,cefoperazone-sulbactam,and piperacillin-tazobactam.Surveillance of bacterial resistance is of great importance for rational use of antibiotics and reducing the emergence of resistance.     

铜陵市部分医院细菌耐药性监测与分析

Objective To investigate the bacterial resistance of clinical isolates collected in Tongling area.Methods The clinical isolates were collected in Tongling area from Jananuary to December in 2007.Antimicrobial susceptibility test were conducted by Kirby-Bauer method.Results Of 1375 clinical isolates,399 strains(29.0%)were gram positive bacteria,and 976 strains(71.0%)were gram negative bacteria.Methicillin resistant staphylococcus aureus(MRSA)accounted for 18.4% of staphylococcus aureus,while methicillin resistant coagulase negative staphylococci(MRCNS)were 70.0% of coagulase negative staphylococci(CNS)respectively.MRSA and MRCNS were highly resistant to gentamicin,ciprofloxacin,clindamycin and erythromycin;but displayed lower resistance to rifampicin,chloramphenicol and nitrofurantion.No vancomycin-resistant staphylococcus strain was found.The resistance rates of Enterococcus faecalis were relatively low to penicillin,ampicillin,nitro furantion,fosfomycin and chloramphenicol.No vancomycin or teicoplanin-resistant enterococcus faecalis was isolated.The resistance rates of E.faecium were lower to fosfomycin and chloramphenicol.Two strains of vancomycin-resistant E.faecium were identified.About of 49.3% of E.coli and 35.9% of Klebsiella isolates produced extended-spectrum β-lactamases(ESBLs).The resistance rates of ESBLs-producing strains to 20 antimicrobial agents were much higher than those of ESBLs nonproducing ones.No imipenem or meropenem-resistant isolate was found.The resistance rate of non-fermenters was lower to imipenem,meropenem,cefoperazone-sulbactam,piperacillin-tazobactam,ceftazidime,cefepime,amikacin or ciprofloxacin.Conclusion The resistance rate of gram positive bacteria is lower to glycopeptides.The resistance rate of gram negative bacilli is lower to imipenem,meropenem,cefoperazone-sulbactam,and piperacillin-tazobactam.Surveillance of bacterial resistance is of great importance for rational use of antibiotics and reducing the emergence of resistance.     

女性泌尿生殖道支原体感染及耐药性分析

Objective To analyze the infection and drug resistance of Ureaplasma urealyticum (Uu) and mycoplasma hominis ( Mh) among female urogenital tract in 2008,hope to provide the data of epidemiology and guide of antibiotics use.Methods Cervical secretion was identified and their antibiotic susceptibility was detected with Mycoplasma IST 2 Reagent from France,the result of mycoplasma cultivation and the sensitivities to antibiotics was analyzed.Results The positive rate of Mycoplasma was 58.6%(610/1 041),among the the 610 positive sample,519(49.9%) cases were Uu positive; 10 cases(1%)were Mh positive;81 ca-ses(7.8%)vrere both Uu and Mh positive;the susceptibility to all these 9 antimicrobial agents in sequence wase Pristinamycin(99.8%)、 Josamycin(99.5%),Doxycycline(96.1 % )、Tetracycline(93.4%) 、Clarithromycin(83.8%)、 Azithromycin(75.9%)、Erythro-mycin(73.4%)、Ofloxacin(27.9%) and Ciprofloxacin(21.8%).Conclusion Mycoplasma (especially Uu) was the main pathogen of urogenital tracts among female with great variation of susceptibility to antibiotics.The sensitive antibiotics should be used to treat the infection of Uu and Mh,such as Pristinamycin,Josamycin,Doxycycline.But Mycoplasma have a high resistance rate to quinolones,that should be paid more attention.     

Prevalence of mild cognitive impairment：a population—based study in elderly veterans

AIM：To explore the prevalence of mild cognitive impairment (MCI) among elderly veterans. METHODS:2 674 veterans (aged 60 years and over) from26 military sanatorium in Shijiazhuang city were evaluated. The Mini-Mental State Examination,Global Deterioration Scale, Activity of Daily Living, Hachinski Ischemic Scale and Hamilton Depression Scale were served as screening tools. RESULTS:The prevalence of total MCI was 8.08% among elderly people. The standardized prevalence of MCI was 6.87% in male and 10.38% in female (P&;lt;0.01). The prevalence of MCI tended to increased with aging (P&;lt;0.01) and decreased with the elevated degree of education (P&;lt;0.05). CONCLUSION:The prevalence of MCI among elderly veterans is lower than that in European and American countries. It should in tensive to monitor the MCI subjects which a high risk Alzheimer disease people. The interventionist treatment for MCI should be turn into the second prevention of the Alzheimer disease.     

整合子在鲍曼不动杆菌耐药中的作用研究

Objective To investigate the drug-resistant status of Acinetobacter baumannii in clinical strains isolated from our hospital,and get to know the distribution of integrons carried by Acinetobacter baumannii,analyze the correlation between integron and drug-resistant of Acinetobacter baumannii..Methods Collected 85 Acinetobacter baumannii isolated in our lab,the drug-sensitivity tests were completed by the method of KB,the integrase genes were amplified by polymerase chain reaction(PCR),and identified the type of integron..Analyzed the correlation between the drug-resistant and integron in Acinetobacter baumannii..The open reading frame of integron were amplified by PCR,the polymorphism of integron was identified,and sequenced the PCR products.Results Except for Imipenem and Cefoperazone/ sulbactam(drug resistant rate less than 10%),the drug resistant rate of other 15 antibacterial was no more than 30% among the 85 Acinetobacter baumannii isolated in our lab..66.1 %(57/85) stains carried the integrons I,we didn't find out the integron Ⅱ and Ⅲ.The drug-resistant rates of Acinetobacter baumannii with integron were higher than that of Acinetobacter baumannii without integron.The length of amplified products in variable region of open reading frame of integron varied from 03 to 25kb,.The sequencing results confirmed the integron included multidrug resistant gene code.Conclusion In our hospital,the drug-resistant rate of Acinetobacter baumannii was high,and the majority were multidrug resistant strains.The drug-resistant rate of Acinetobacter baumannii was enhanced with integron,The multidrug resistant of Acinetobacter baumannii was associated with integrons.     

DETECTION OF HIGH-PATHOGENICITY ISLAND-HARBORING ESCHERICHIA COLI ISOLATED FROM CHILDREN WITH DIARRHEA DISEASE IN CHINA

[Objective] To investigate the etiologicla status of etiologica status of high-pathogenicity island-harboring Escherichia coil(HPIEC) in dianhea disease among children. [Method] Diarrheagenic Esoherichia coli was isolated and identified from the stool specimens of 1032 children with dianhea diseases by culturing, serotyping, Polymerase chain reaction amplification (PCR), the High-pathogenicity island-harboring Esoherichia coli (HPIEC) was identified by PCR and in situ hybridization. [Results] A total of 652 strains of E.coli isolated from 1032 stool specimens and confirmed by serotyping, PCR and colony hybridization out of which 225 were identified as diarrheagenic E.coil,including 20 EPEC,81 ETEC, 47 SLTEC, 74 ESIEC, and 3 EIEC strains. 112(17.2%)irp2 virulent gene positive E.coli (HPIEC) were detected from the 652 strains, out of which 24 were from the 74 ESIEC strains and 17 from the 47 SLTEC strains. The typical clinical symptoms of children with diarrhea disease caused by HPI- harboring E.coli included anorexia(87.5%) ,abdominal pain(58.0%), diarrhea (75.9%,Over six episoders, mostly of mucous stool a day), and fever(50.9%). [Conclusion] High-pathogenicity island-harboring E.coli is one of the important pathogens of diarrhea diseases in children.     

Utility of a rapid diagnosis kit for <Emphasis Type="Italic">Mycoplasma pneumoniae</Emphasis> pneumonia in children,and the antimicrobial susceptibility of the isolates

We evaluated a kit for the rapid diagnosis of Mycoplasma pneumoniae infection and investigated the antimicrobial susceptibility of the isolates. A total of 194 otherwise healthy children, aged 0.3–14.9 years, were diagnosed as having pneumonia by chest X-ray findings between December 2003 and November 2004, and were admitted to Showa Hospital. Isolation of M. pneumoniae was attempted from a throat swab obtained on admission, and the complement fixation titer was measured in paired serum samples obtained at admission and at the convalescent stage. We also used a rapid diagnosis kit (ImmunoCard Mycoplasma) for the detection of specific immunoglobulin M antibody in paired sera. Pneumonia due to M. pneumoniae was defined by isolation of this microorganism, or by seroconversion, or a ≥4-fold increase in the antibody titer. Using each isolate, we determined the minimum inhibitory concentrations for five antimicrobial agents by the broth dilution method. M. pneumoniae pneumonia was diagnosed in 45 children (23.2%). The ImmunoCard had a sensitivity of 31.8% using admission serum and 88.6% using paired sera, while the specificity was 78.1% and 70.5%, respectively. M. pneumoniae was isolated from 14 of the 45 patients (31.1%). The 50%/90% minimum inhibitory concentration (μg/ml) of erythromycin, clarithromycin, azithromycin, minocycline, and levofloxacin was 0.006/0.012, ≤0.003/≤0.003, ≤0.003/≤0.003, 0.78/1.56, and 0.39/0.78, respectively. For a rapid diagnosis of M. pneumoniae pneumonia, the ImmunoCard was not effective. Macrolides showed superior in vitro antimicrobial activity against M. pneumoniae isolates causing pediatric pneumonia.     

Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates

We prospectively investigated the relationship between the clinical efficacy of treatment of pulmonary Mycobacterium avium complex (MAC) disease and drug-sensitivity testing of MAC isolates for antituberculous drugs, new quinolone antibiotics, and clarithromycin (CAM). Fifty-two patients who satisfied the diagnostic criteria of the American Thoracic Society (ATS) and who received treatment between April 1998 and December 2005, using combined therapy of rifampicin (RFP), ethambutol (EB), streptomycin (SM), and CAM, were enrolled in this study. The causative microorganisms isolated were Mycobacterium avium in 30 patients and M. intracellulare in 22 patients. Although separation of the two strains showed drug sensitivity testing to have slightly better minimal inhibitory concentrations (MIC) for M. intracellulare than for M. avium, there were no significant differences in the sputum eradication rate or clinical improvement between the two strains. The MICs of various antibiotics for the isolated MAC strains were as follows: RFP, 0.125–8 μg/ml; CAM, 0.25–16 μg/ml; SM, 2–128≦ μg/ml; EB, 128≦ μg/ml; levofloxacin (LVFX), 1–32 μg/ml; sparfloxacin (SPFX), 0.5–16 μg/ml; and gatifloxacin (GFLX), 0.25–8 μg/ml. The isolated MAC strains showed the same excellent drug sensitivity test results for RFP, new quinolones, and CAM, but they showed resistant drug-sensitivity results for EB and SM. Regarding the relationship between clinical efficacy and the MICs of RFP, EB, CAM, and SM, there was a good relationship only for CAM. Although the ATS has not yet recommended routine drug susceptibility testing of CAM, we believe that drug susceptibility testing of CAM should be performed before the initial treatment is undertaken for pulmonary MAC disease.     

多重耐药不动杆菌16S rRNA甲基化酶和同源性研究

Objective To characterize 16S rRNA methylase encoding genes associated with aminoglycoaides resistance, gene cassettes of class Ⅰ integrons of the multidrug-resistant Acinetobctcter spp. The sixty one Acinetobacter isolates were collected at the Second Hospital of Shanxi Medical Uni versity from July, 2007 to May, 2008. Methods Species identification was confirmed by sequence analysis of the blaOXA-51-like gene and 16S-23S rRNA gene space-region. Antimierobial susceptibility tests were performed by agar dilution method. 16S rRNA methylaae encoding genes and gene cassettes associated with integrons were amplified by PCR method. Results Among the sixty one strains, there were fifty five of Acinetobacter baumannii, three genospecies 3TU, one 13TU, one Aeinetobaeter ealcoacetieus, and one Aeinetobaeter haemolytieus. Forty eight isolates showed high-level resistance to three aminoglyeosides, including amikaein, tobramyein and gentamicin. The armA gene was found in 47 isolates and all isolates were negative for rmtA, rmtB, rmtC and rmtD genes. The Intl gene was found in 27 isolates. The gene cassettes contained arr-3, accA4,ctacCI ,catB8, aadA1 or dfrA12 genes. According to the PFGE DNA patterns, 5 distinct clones of armA-pasitive strains were identified. Clone A and Clone B were the dominant clones, widely distributed among different divisions. Condnsions 16S rRNA methylase encoding gene (armA) distributed widely in muhidrug-resistant Acinetobacter spp. The armA gene is not located in class Ⅰintegron. The class Ⅰ integron carries multiple resistant genes associated with aminoglycosides and chloramphenieol resistance.PFGE analysis suggests that armA-pesitive strains are widely spread in our hospitaL Effective infection control measure should be conducted in order to control the outbreak of resistant bacteria.     

多重耐药不动杆菌16S rRNA甲基化酶和同源性研究

Objective To characterize 16S rRNA methylase encoding genes associated with aminoglycoaides resistance, gene cassettes of class Ⅰ integrons of the multidrug-resistant Acinetobctcter spp. The sixty one Acinetobacter isolates were collected at the Second Hospital of Shanxi Medical Uni versity from July, 2007 to May, 2008. Methods Species identification was confirmed by sequence analysis of the blaOXA-51-like gene and 16S-23S rRNA gene space-region. Antimierobial susceptibility tests were performed by agar dilution method. 16S rRNA methylaae encoding genes and gene cassettes associated with integrons were amplified by PCR method. Results Among the sixty one strains, there were fifty five of Acinetobacter baumannii, three genospecies 3TU, one 13TU, one Aeinetobaeter ealcoacetieus, and one Aeinetobaeter haemolytieus. Forty eight isolates showed high-level resistance to three aminoglyeosides, including amikaein, tobramyein and gentamicin. The armA gene was found in 47 isolates and all isolates were negative for rmtA, rmtB, rmtC and rmtD genes. The Intl gene was found in 27 isolates. The gene cassettes contained arr-3, accA4,ctacCI ,catB8, aadA1 or dfrA12 genes. According to the PFGE DNA patterns, 5 distinct clones of armA-pasitive strains were identified. Clone A and Clone B were the dominant clones, widely distributed among different divisions. Condnsions 16S rRNA methylase encoding gene (armA) distributed widely in muhidrug-resistant Acinetobacter spp. The armA gene is not located in class Ⅰintegron. The class Ⅰ integron carries multiple resistant genes associated with aminoglycosides and chloramphenieol resistance.PFGE analysis suggests that armA-pesitive strains are widely spread in our hospitaL Effective infection control measure should be conducted in order to control the outbreak of resistant bacteria.